Stigma, Disclosure, Coping, and Medication Adherence Among People Living with HIV/AIDS in Northern Tanzania

R.A. Lyimo, S.E. Stutterheim, H.J. Hospers, T. De Glee, A. Van Der Ven, M. De Bruin

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

This study examines a proposed theoretical model examining the interrelationships between stigma, disclosure, coping, and medication adherence among 158 HIV-infected patients on antiretroviral therapy (ART) in northern Tanzania. Perceived and self-stigma, voluntary and involuntary disclosure, positive and negative coping, and demographics were assessed by trained interviewers, and self-reported adherence was collected during 5 months follow-up. Data were examined using correlation and regression analyses. The analyses showed that perceived stigma is primarily related to involuntary disclosure, whereas self-stigma is related to voluntary disclosure. Religious coping positively relates to acceptance, whereas perceived stigma explains higher levels of denial of HIV status. Lastly, adherence was negatively affected by alcohol use, self-stigma, and denial. We conclude that adherence is predominantly predicted by negative rather than positive coping mechanisms. Therefore, substituting maladaptive coping mechanisms like denial and alcohol use with a more adaptive coping style may be an important strategy to improve long-term ART adherence and well-being of patients. Moreover, this study showed that it is useful to examine both involuntary and voluntary disclosure when studying its relation with stigma.

Original languageEnglish
Pages (from-to)98-105
Number of pages8
JournalAIDS Patient Care and STDs
Volume28
Issue number2
DOIs
Publication statusPublished - 11 Feb 2014

Fingerprint

Tanzania
Medication Adherence
Disclosure
Acquired Immunodeficiency Syndrome
HIV
Alcohols
Theoretical Models
Regression Analysis
Demography
Interviews
Therapeutics
Denial (Psychology)

Keywords

  • HIV-related stigma
  • African-American women
  • Dar-Es-Salaam
  • social support
  • antiretroviral adherence
  • serostatus disclosure
  • mental-health
  • South-Africa
  • therapy
  • metaanalysis

Cite this

Stigma, Disclosure, Coping, and Medication Adherence Among People Living with HIV/AIDS in Northern Tanzania. / Lyimo, R.A.; Stutterheim, S.E.; Hospers, H.J.; De Glee, T.; Van Der Ven, A.; De Bruin, M.

In: AIDS Patient Care and STDs, Vol. 28, No. 2, 11.02.2014, p. 98-105.

Research output: Contribution to journalArticle

Lyimo, R.A. ; Stutterheim, S.E. ; Hospers, H.J. ; De Glee, T. ; Van Der Ven, A. ; De Bruin, M. / Stigma, Disclosure, Coping, and Medication Adherence Among People Living with HIV/AIDS in Northern Tanzania. In: AIDS Patient Care and STDs. 2014 ; Vol. 28, No. 2. pp. 98-105.
@article{b4fdcc3c445d4555871958970c717f36,
title = "Stigma, Disclosure, Coping, and Medication Adherence Among People Living with HIV/AIDS in Northern Tanzania",
abstract = "This study examines a proposed theoretical model examining the interrelationships between stigma, disclosure, coping, and medication adherence among 158 HIV-infected patients on antiretroviral therapy (ART) in northern Tanzania. Perceived and self-stigma, voluntary and involuntary disclosure, positive and negative coping, and demographics were assessed by trained interviewers, and self-reported adherence was collected during 5 months follow-up. Data were examined using correlation and regression analyses. The analyses showed that perceived stigma is primarily related to involuntary disclosure, whereas self-stigma is related to voluntary disclosure. Religious coping positively relates to acceptance, whereas perceived stigma explains higher levels of denial of HIV status. Lastly, adherence was negatively affected by alcohol use, self-stigma, and denial. We conclude that adherence is predominantly predicted by negative rather than positive coping mechanisms. Therefore, substituting maladaptive coping mechanisms like denial and alcohol use with a more adaptive coping style may be an important strategy to improve long-term ART adherence and well-being of patients. Moreover, this study showed that it is useful to examine both involuntary and voluntary disclosure when studying its relation with stigma.",
keywords = "HIV-related stigma, African-American women, Dar-Es-Salaam, social support, antiretroviral adherence, serostatus disclosure, mental-health, South-Africa, therapy, metaanalysis",
author = "R.A. Lyimo and S.E. Stutterheim and H.J. Hospers and {De Glee}, T. and {Van Der Ven}, A. and {De Bruin}, M.",
year = "2014",
month = "2",
day = "11",
doi = "10.1089/apc.2013.0306",
language = "English",
volume = "28",
pages = "98--105",
journal = "AIDS Patient Care and STDs",
issn = "1087-2914",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

TY - JOUR

T1 - Stigma, Disclosure, Coping, and Medication Adherence Among People Living with HIV/AIDS in Northern Tanzania

AU - Lyimo, R.A.

AU - Stutterheim, S.E.

AU - Hospers, H.J.

AU - De Glee, T.

AU - Van Der Ven, A.

AU - De Bruin, M.

PY - 2014/2/11

Y1 - 2014/2/11

N2 - This study examines a proposed theoretical model examining the interrelationships between stigma, disclosure, coping, and medication adherence among 158 HIV-infected patients on antiretroviral therapy (ART) in northern Tanzania. Perceived and self-stigma, voluntary and involuntary disclosure, positive and negative coping, and demographics were assessed by trained interviewers, and self-reported adherence was collected during 5 months follow-up. Data were examined using correlation and regression analyses. The analyses showed that perceived stigma is primarily related to involuntary disclosure, whereas self-stigma is related to voluntary disclosure. Religious coping positively relates to acceptance, whereas perceived stigma explains higher levels of denial of HIV status. Lastly, adherence was negatively affected by alcohol use, self-stigma, and denial. We conclude that adherence is predominantly predicted by negative rather than positive coping mechanisms. Therefore, substituting maladaptive coping mechanisms like denial and alcohol use with a more adaptive coping style may be an important strategy to improve long-term ART adherence and well-being of patients. Moreover, this study showed that it is useful to examine both involuntary and voluntary disclosure when studying its relation with stigma.

AB - This study examines a proposed theoretical model examining the interrelationships between stigma, disclosure, coping, and medication adherence among 158 HIV-infected patients on antiretroviral therapy (ART) in northern Tanzania. Perceived and self-stigma, voluntary and involuntary disclosure, positive and negative coping, and demographics were assessed by trained interviewers, and self-reported adherence was collected during 5 months follow-up. Data were examined using correlation and regression analyses. The analyses showed that perceived stigma is primarily related to involuntary disclosure, whereas self-stigma is related to voluntary disclosure. Religious coping positively relates to acceptance, whereas perceived stigma explains higher levels of denial of HIV status. Lastly, adherence was negatively affected by alcohol use, self-stigma, and denial. We conclude that adherence is predominantly predicted by negative rather than positive coping mechanisms. Therefore, substituting maladaptive coping mechanisms like denial and alcohol use with a more adaptive coping style may be an important strategy to improve long-term ART adherence and well-being of patients. Moreover, this study showed that it is useful to examine both involuntary and voluntary disclosure when studying its relation with stigma.

KW - HIV-related stigma

KW - African-American women

KW - Dar-Es-Salaam

KW - social support

KW - antiretroviral adherence

KW - serostatus disclosure

KW - mental-health

KW - South-Africa

KW - therapy

KW - metaanalysis

UR - http://www.scopus.com/inward/record.url?scp=84894195802&partnerID=8YFLogxK

U2 - 10.1089/apc.2013.0306

DO - 10.1089/apc.2013.0306

M3 - Article

AN - SCOPUS:84894195802

VL - 28

SP - 98

EP - 105

JO - AIDS Patient Care and STDs

JF - AIDS Patient Care and STDs

SN - 1087-2914

IS - 2

ER -